NCT06505499

Brief Summary

Instrumented three dimensional gait analysis (3DGA) permits to record spatial, temporal, kinetics, kinematics and electromyographic (EMG) parameters in order to understand gait impairment in children and teenagers with cerebral palsy (CP). Nowadays, single-event multilevel surgery in subjects with CP cannot be performed without 3DGA. However, interpretation of multiple and interdependent data remains complex for the clinician. To address this issue, gait statistical index have been developed to give a single measure of the quality of the gait pattern. Among actual index, the Gait Profile Score (GPS), developed by Baker et al (2009), measure the deviation of kinematics parameters from a controlled dataset. The GPS can be divided in nine Gait Variable Score (GVS), corresponding to major lower limb joints: the MAP (Movement Analysis Profile). Many studies have reported the interest of the GPS to analysis gait of subjects with CP: good inter-session reliability, predictor of postoperative kinematic improvement, minimal clinical threshold calculated at 1.6°, significant relationship with clinical data (joint contractures), and sensibility to change after a single-event multilevel surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 17, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

January 10, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

July 11, 2024

Last Update Submit

January 9, 2025

Conditions

Keywords

Cerebral palsyGait profile scoreBotulinum toxin injectionMultilevel surgery

Outcome Measures

Primary Outcomes (1)

  • Degrees of Gait Profile Score overall

    Analyze Degrees of Gait Profile Score overall

    Day 1

Secondary Outcomes (2)

  • Gait Profile Score right

    Month 2

  • Gait Profile Score left

    Year 2

Study Arms (1)

EXPERIMENTAL GROUP

Children and teenagers with CP with an instrumented gait analysis performed since 2019.

Other: Gait Profile ScoreOther: Gait Visual Score

Interventions

Gait Profile Score in degrees, calculated from kinematic raw data with the Gdi\_GPS\_calculator spreadsheet developed by Baker (2009).

EXPERIMENTAL GROUP

Gait Visual Score in degrees, calculated from kinematic raw data with the Gdi\_GPS\_calculator spreadsheet developed by Baker (2009)

EXPERIMENTAL GROUP

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children and adolescents with cerebral palsy treated at the Saint-Etienne University Hospital will be included.

You may qualify if:

  • Etiology of cerebral palsy
  • Unilateral, bilateral, triplegic or quadriplegic forms of cerebral palsy.
  • to 18 years old
  • GMFCS (Gross Motor Function Classification System) I to III
  • Instrumented gait analysis of the laboratory of St-Etienne
  • Absence of botulinum toxin injection or serial casting in the three months after a first instrumented gait analysis.

You may not qualify if:

  • Etiology others than cerebral palsy as defined classically (ex: ischemic infarcts in a child older than two years).
  • Previous surgery in lower-limb.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu de Saint Etienne

Saint-Etienne, 42000, France

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Clément BOULARD, physiotherapist

    CHU de Saint-Etienne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 17, 2024

Study Start

March 6, 2024

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

January 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations